GlassScriptPhysician profile
Jocelyn Burke
NPI 1538393244
$29,533.47
in general payments reported to CMS, 2019-2025
21 companies · $825 in 2025
The $825 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $398 · 2021: $526 · 2022: $9,977 · 2023: $5,999 · 2024: $893 · 2025: $825.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,195 · Food and Beverage: $2,802 · Travel and Lodging: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,195.40 |
| Food and Beverage | $2,801.54 |
| Travel and Lodging | $720.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $19,429.11 | 2019-2025 | Davinci Xi, Da Vinci Surgical System |
| Abbvie INC. | $5,126.71 | 2019-2025 | |
| Ethicon US, LLC | $1,582.50 | 2019-2025 | Linx Reflux Management System, Echelon Flex, Stratafix |
| Medical Device Business Services, INC. | $927.71 | 2019 | |
| Lucid Diagnostics INC. | $633.86 | 2023-2025 | |
| Tela Bio, INC. | $393.44 | 2021-2024 | Ovitex 2s |
| Davol INC. | $344.22 | 2019-2023 | Phasix Mesh |
| Endogastric Solutions, INC | $334.58 | 2021-2023 | Esophyx |
| Medtronic, INC. | $143.40 | 2021-2024 | Endoflip |
| Tactile Systems Technology INC | $107.37 | 2024 | Entre Plus, Flexitouch Plus |
| Mauna Kea Technologies, INC. | $87.11 | 2019 | |
| Ethicon INC. | $86.55 | 2019 | |
| Acera Surgical, INC. | $85.53 | 2023-2025 | Restrata Wound Matrix |
| Stryker Corporation | $68.45 | 2024 | 1788 |
| Mentor Worldwide LLC | $60.39 | 2021-2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $27.87 | 2020 | |
| Abbott Laboratories | $24.09 | 2024 | Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $22.17 | 2024 | Gattex |
| Smith+Nephew, INC. | $18.87 | 2022 | |
| Integra Lifesciences Corporation | $18.52 | 2023 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Boston Scientific Corporation | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocelyn Burke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.